Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial

被引：0

作者：

Pudipeddi, A. ^{[1
,2
,3
]}

Lin, H. ^{[4
]}

Paramsothy, S. ^{[1
,3
]}

Kariyawasam, V ^{[1
,5
]}

Paramsothy, R. ^{[6
]}

Ghaly, S. ^{[7
,8
]}

Haifer, C. ^{[7
,8
]}

An, Y. K. ^{[9
,10
]}

Begun, J. ^{[9
,10
]}

Connor, S. ^{[11
,12
]}

Corte, C. ^{[13
]}

Ward, M. ^{[14
]}

De Cruz, P. ^{[15
,16
]}

Fung, C. ^{[17
]}

Redmond, D. ^{[1
]}

Chan, W. ^{[18
]}

Mourad, F. ^{[19
]}

Kermeen, M. ^{[1
]}

Leong, R. ^{[1
,3
,5
]}

机构：

[1] Concord Repatriat Gen Hosp, Gastroenterol & Liver Serv, Sydney, Australia

[2] Australian Natl Univ, Coll Med & Hlth, Sydney, Australia

[3] Univ Sydney, Fac Med & Hlth, Sydney, Australia

[4] Tan Tock Seng Hosp, Gastroenterol & Hepatol, Singapore City, Singapore

[5] Macquarie Univ, Fac Med & Hlth Sci, Sydney, Australia

[6] Univ Sydney, Fac Med & Hlth, Sydney, Australia

[7] St Vincents Hosp, Gastroenterol & Hepatol, Sydney, Australia

[8] Univ New South Wales, Sch Clin Med, St Vincents Healthcare Campus, Sydney, Australia

[9] Mater Hosp, Dept Gastroenterol, Brisbane, Australia

[10] Univ Queensland, Mater Res Inst, Brisbane, Australia

[11] Liverpool Hosp, Dept Gastroenterol, Sydney, Australia

[12] Univ New South Wales, UNSW Med & Hlth, South West Sydney Clin Campuses, Sydney, Australia

[13] Royal Prince Alfred Hosp, AW Morrow Gastroenterol Ctr, Sydney, Australia

[14] Alfred Hosp, Dept Gastroenterol, Melbourne, Australia

[15] Austin Hosp, Dept Gastroenterol, Melbourne, Australia

[16] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Australia

[17] Concord Repatriat Gen Hosp, Dept Anat Pathol, Sydney, Australia

[18] Singapore Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore

[19] American Univ, Beirut Med Ctr, Gastroenterol, Beirut, Lebanon

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.0928

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0754

引用

页码：I1453 / I1454

页数：2

共 26 条

[1] WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL
Pudipeddi, Aviv
Paramsothy, Sudarshan
Kariyawasam, Viraj C.
Paramsothy, Ramesh
Ghaly, Dr Simon
Haifer, Craig
An, Yoon-Kyo
Begun, Jakob
Connor, Susan J.
Corte, Crispin
Ward, Mark
De Cruz, Peter
Fung, Caroline
Chan, Pak Wo
Mourad, Fadi H.
Redmond, Diane
Leong, Rupert
GASTROENTEROLOGY, 2023, 164 (06) : S221 - S221
[2] Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial
Pudipeddi, A.
Paramsothy, S.
Kariyawasam, V.
Paramsothy, R.
Ghaly, S.
Haifer, C.
An, Y. K.
Begun, J.
Connor, S.
Corte, C.
Ward, M.
De Cruz, P.
Fung, C.
Redmond, D.
Leong, R. W.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 542 - 542
[3] Disease clearance and extended disease clearance in patients with ulcerative colitis in the Vedolizumab Immunomodulator Enforced Withdrawal Study (VIEWS): Predictive factors and long-term outcomes
Lin, H.
Pudipeddi, A.
Paramsothy, S.
Mohsen, W.
Connor, S.
Chan, W.
Mourad, F.
Kariyawasam, V.
Yau, Y.
Fung, C.
Leong, R.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 155 - 156
[4] The Impact of Mirikizumab Induction, Maintenance, and Long-Term Treatment on Disease Clearance in Patients With Moderately to Severely Active Ulcerative Colitis: Post-Hoc Analysis of LUCENT Trials
Colombel, Jean-Frederic
Kobayashi, Taku
Wu, Jianmin
Zhu, Baojin
Jairath, Vipul
Redondo, Isabel
Moses, Richard
Siegel, Corey A.
Siegmund, Britta
Magro, Fernando
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1079 - S1080
[5] Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial
Jairath, Vipul
Peyrin-Biroulet, Laurent
Zou, Guangyong
Mosli, Mahmoud
Vande Casteele, Niels
Pai, Reetesh K.
Valasek, Mark A.
Marchal-Bressenot, Aude
Stitt, Larry W.
Shackelton, Lisa M.
Khanna, Reena
D'Haens, Geert R.
Sandborn, William J.
Olson, Allan
Feagan, Brian G.
Pai, Rish K.
GUT, 2019, 68 (07) : 1162 - 1168
[6] Left ventricular volume change and long-term outcomes in ischaemic cardiomyopathy with or without surgical revascularisation: A post-hoc analysis of a randomised controlled trial
Zhou, Zhuoming
Zhuang, Xiaodong
Liu, Menghui
Jian, Bohao
Fu, Guangguo
Liao, Xinxue
Wu, Zhongkai
Liang, Mengya
ECLINICALMEDICINE, 2022, 53
[7] Hospitalisation and surgery rates in patients with Ulcerative Colitis and Crohn's disease treated with subcutaneous vedolizumab: Long-term findings from the VISIBLE OLE study
Vermeire, S.
Jones, S.
Velazco, N.
Agboton, C.
Wojtowicz, A. M.
Young, L.
Phillips, R.
Loftus-Jr., E., V
Danese, S.
D'Haens, G.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1605 - I1605
[8] Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial
Schreiber, S.
Feagan, B.
Peyrin-Biroulet, L.
Vermeire, S.
Faes, M.
Harris, K.
Oortwijn, A.
Daniele, P.
Patel, H.
Danese, S.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I007 - I008
[9] LONG-TERM REMISSION WITH CARIPRAZINE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA: A POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, RELAPSE PREVENTION TRIAL
Potkin, Steven
Correll, Christoph
Chang, Cheng-Tao
Szatmari, Balÿzs
Laszlovszky, Istvan
Earley, Willie
SCHIZOPHRENIA BULLETIN, 2017, 43 : S118 - S118
[10] Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial
Correll, Christoph U.
Potkin, Steven G.
Zhong, Yan
Harsanyi, Judit
Szatmari, Balazs
Earley, Willie
JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (02)

← 1 2 3 →